Indrayani Biotech Financials

BSE: 526445

₹8.56

₹0.40 (4.90%)

As on 12-Nov-2026 15:32IST

Market cap

₹46 Cr

Revenue (TTM)

₹181 Cr

P/E Ratio

22

P/B Ratio

0.5

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Operating Revenue	181.45	137.83	130.23	166.23	162.93	61.57
Total Income	187.39	142.40	133.35	167.44	167.41	61.79
Total Expenditure	169.74	128.20	123.85	142.57	145.62	54.79
EBITDA	11.70	0.76	6.38	23.66	17.31	6.78
Depreciation	5.55	4.30	3.37	3.80	3.35	0.66
EBIT	6.16	-3.54	3.01	19.86	13.96	6.12
Interest	11.27	9.60	11.88	10.10	5.64	1.89
Other Income	5.94	4.57	3.13	1.21	4.49	0.22
Exceptional Items	--	--	--	--	-0.50	--
Profit before Tax	0.82	0.30	-5.74	10.97	12.31	4.44
Provision for Tax	-1.84	-1.86	0.36	0.55	0.38	--
Profit after Tax	2.66	2.16	-6.11	10.42	11.93	4.44
Minority Interest	-0.56	--	4.55	-4.06	-3.19	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	2.10	2.16	-1.56	6.36	8.74	4.44

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Shareholder's Funds	72.89	72.89	72.51	67.21	55.09	24.16
Minority Interest	-0.56	--	27.41	9.05	-6.73	0.41
Non-Current Liabilities	58.36	58.36	65.54	70.33	35.66	7.35
Current Liabilities	92.98	92.98	102.48	87.07	71.91	19.48
Total Liabilities	253.43	253.43	267.94	234.00	155.95	51.40

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Non-Current Assets	89.67	89.67	90.00	88.69	78.40	32.49
Current Assets	158.72	158.72	177.94	144.98	77.52	18.91
Total Assets	253.43	253.43	267.94	234.00	155.95	51.40
Total Debt*	--	--	137.07	107.66	62.75	17.89
Net Current Assets	65.74	65.74	75.45	57.90	5.61	-0.57
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Cash From Operating Activities	--	--	-6.74	-30.35	16.19	4.11
Cash Flow from Investing Activities	--	--	24.74	-16.34	-47.39	-0.56
Cash from Financing Activities	--	--	-18.30	44.24	32.74	-2.73
Net Cash Inflow / Outflow	--	--	-0.29	-2.45	1.53	0.82

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Adjusted EPS (₹)	0.46	0.47	-0.37	1.53	2.80	1.42
Cash EPS (₹)	0.39	-1.74	-0.66	3.42	4.89	1.63
Adjusted Book Value (₹)	15.95	16.67	16.61	15.19	14.18	7.74
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	--	-1.48	-6.67	4.73	1.20
Free Cash Flow per Share (₹)	--	--	-4.82	-12.41	-9.71	0.30

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
ROCE (%)	--	--	3.19	14.40	22.45	16.38
ROE (%)	2.82	2.91	-9.25	19.41	34.86	20.23
ROA (%)	1.02	0.83	-2.44	5.35	11.51	9.71
EBIT Margin (%)	3.39	-2.57	2.31	11.94	8.57	9.94
Net Margin (%)	1.42	1.52	-4.58	6.22	7.13	7.18
Cash Profit Margin (%)	--	--	-2.10	8.56	9.38	8.28

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Revenue Growth (%)	41.97	5.84	-21.66	2.02	164.61	191.97
EBIT Growth (%)	475.77	-217.82	-84.85	42.21	128.08	213.33
Net Profit Growth (%)	127.87	135.36	-158.60	-12.64	168.74	139.59
EPS Growth (%)	127.26	135.36	-124.45	-45.24	96.79	139.92
Book Value Growth (%)	--	--	9.39	42.45	83.31	22.53

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Price / Earnings	22.00	16.57	--	35.18	22.14	23.51
Price / Book Value	0.54	0.47	0.86	3.24	3.98	3.94
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	9.65	17.92	21.23	13.31	12.04	17.25
Close Price (₹)	9.00	7.92	15.63	53.89	61.94	33.43
High Price (₹)	18.08	22.36	71.96	109.28	126.81	34.42
Low Price (₹)	6.69	6.69	15.43	51.30	30.52	5.21
Market Cap (₹ Cr)	46.14	35.79	64.93	223.91	193.41	104.39

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Debt to Equity	0.79	0.79	1.99	1.71	1.17	0.74
Short term debt to equity ratio	--	--	0.97	0.59	0.58	0.46
Current Ratio	1.71	1.71	1.74	1.67	1.08	0.97
Quick Ratio	1.30	1.30	1.33	1.18	0.91	0.89
Interest Coverage	1.07	1.03	0.52	2.09	3.18	3.35

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-12	Mar-11	Mar-10
Debtors to sales (%)	32.28	42.50	45.07	23.78	18.40	22.90
Asset Turnover	0.70	0.53	0.52	0.85	1.57	1.35
Receivable days	--	--	137.64	76.31	49.36	55.92
Inventory Days	--	--	117.29	59.91	15.40	7.77
Payable days	--	--	134.44	112.97	50.99	40.71
Cash Conversion Cycle	--	--	120.49	23.24	13.77	22.98

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.